
Yes, assuming the merger closes as announced, Iridium (NASDAQ: IRDM) would no longer trade as a standalone public company. It would effectively be delisted because it will become a wholly owned subsidiary of Rocket Lab.
Here’s what happens:
- Rocket Lab will acquire 100% of the outstanding Iridium shares in a transaction valued at $54 per IRDM share.
- Each Iridium shareholder will receive:
- $27 in cash, plus
- Rocket Lab (RKLB) shares, with the number of shares determined by an exchange ratio tied to Rocket Lab’s stock price (subject to a collar).
Once the acquisition closes:
- ✅ IRDM shares will stop trading on Nasdaq.
- ✅ Your brokerage account will automatically replace your IRDM shares with the cash and RKLB shares you’re entitled to.
- ✅ The ticker IRDM will be retired unless Rocket Lab chooses some unusual structure (which has not been announced).
Timeline
The companies expect the transaction to close in mid-2027, subject to:
- Iridium shareholder approval
- Regulatory approvals
- Other customary closing conditions.
If you own IRDM today
You have three basic choices:
- Sell before closing if you don’t want Rocket Lab shares.
- Hold through closing to receive the merger consideration (cash + RKLB stock).
- If the deal falls apart, IRDM would continue trading independently, although its stock price could fall back toward its standalone valuation.
One point to watch is the collar on the stock portion. The value is designed to equal $54 per IRDM share, but the number of RKLB shares you receive changes depending on Rocket Lab’s share price at closing.
For more information: https://investors.rocketlabcorp.com/news-releases/news-release-details/rocket-lab-acquire-iridium-historic-deal-creating-fully
** This is not financial advice. Do you own due diligence and/or consult with a licensed financial advisory prior to making financial decisions.








